NCT03647566View on ClinicalTrials.gov

18F Sodium Fluoride PET/CT in Acute Aortic Syndrome

CompletedOBSERVATIONAL
Enrollment

76

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

February 1, 2021

Study Completion Date

February 1, 2021

Conditions
Acute Aortic SyndromeAortic DissectionPenetrating Aortic UlcerIntramural Hematoma
Interventions
DIAGNOSTIC_TEST

18F Sodium Fluoride Positron Emission Tomography / Computed Tomography

PET scan using the 18F-Sodium Fluoride radiotracer followed by an attenuation correction CT scan

DIAGNOSTIC_TEST

CT Aortic Angiogram

CT scan to assess aortic morphology and contextualise PET scan

DIAGNOSTIC_TEST

Aortic MRI

Aortic MRI to assess aortic morphology and contextualise PET scan

Trial Locations (1)

EH16 4SA

Royal Infirmary of Edinburgh, Edinburgh

All Listed Sponsors
collaborator

NHS Lothian

OTHER_GOV

collaborator

British Heart Foundation

OTHER

lead

University of Edinburgh

OTHER

NCT03647566 - 18F Sodium Fluoride PET/CT in Acute Aortic Syndrome | Biotech Hunter | Biotech Hunter